NJ Bio, Inc. and Ajinomoto Bio‐Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development
PRINCETON, N.J. and TOKYO, April 1, 2026 /PRNewswire/ -- NJ Bio, Inc. ("NJ Bio"), a leading provider of integrated drug discovery and development services and Ajinomoto Bio‐Pharma Services ("Aji Bio‐Pharma"), a leading provider of biopharmaceutical manufacturing services and platform...
2026-03-31 23:00:00